BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 16741755)

  • 21. Omega-conotoxin GVIA potently inhibits the currents mediated by P2X receptors in rat DRG neurons.
    Lalo UV; Pankratov YV; Arndts D; Krishtal OA
    Brain Res Bull; 2001 Mar; 54(5):507-12. PubMed ID: 11397540
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Actions of cannabinoids on membrane properties and synaptic transmission in rat periaqueductal gray neurons in vitro.
    Vaughan CW; Connor M; Bagley EE; Christie MJ
    Mol Pharmacol; 2000 Feb; 57(2):288-95. PubMed ID: 10648638
    [TBL] [Abstract][Full Text] [Related]  

  • 23. P2X2 receptors differentiate placodal vs. neural crest C-fiber phenotypes innervating guinea pig lungs and esophagus.
    Kwong K; Kollarik M; Nassenstein C; Ru F; Undem BJ
    Am J Physiol Lung Cell Mol Physiol; 2008 Nov; 295(5):L858-65. PubMed ID: 18689601
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cannabinoids inhibit the formation of new synapses between hippocampal neurons in culture.
    Kim D; Thayer SA
    J Neurosci; 2001 May; 21(10):RC146. PubMed ID: 11319244
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute hypertension reveals depressor and vasodilator effects of cannabinoids in conscious rats.
    Ho WS; Gardiner SM
    Br J Pharmacol; 2009 Jan; 156(1):94-104. PubMed ID: 19133994
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [ATP receptors in pain].
    Tsuda M; Koizumi S; Inoue K
    Nihon Yakurigaku Zasshi; 2000 Dec; 116(6):343-50. PubMed ID: 11188502
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of cannabinoids on endogenous K+ and Ca2+ currents in HEK293 cells.
    Vásquez C; Navarro-Polanco RA; Huerta M; Trujillo X; Andrade F; Trujillo-Hernández B; Hernández L
    Can J Physiol Pharmacol; 2003 May; 81(5):436-42. PubMed ID: 12774849
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of long-term potentiation in rat hippocampal slices by anandamide and WIN55212-2: reversal by SR141716 A, a selective antagonist of CB1 cannabinoid receptors.
    Terranova JP; Michaud JC; Le Fur G; Soubrié P
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Nov; 352(5):576-9. PubMed ID: 8751088
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TNP-ATP-resistant P2X ionic current on the central terminals and somata of rat primary sensory neurons.
    Tsuzuki K; Ase A; Séguéla P; Nakatsuka T; Wang CY; She JX; Gu JG
    J Neurophysiol; 2003 Jun; 89(6):3235-42. PubMed ID: 12783957
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anandamide-mediated CB1/CB2 cannabinoid receptor--independent nitric oxide production in rabbit aortic endothelial cells.
    McCollum L; Howlett AC; Mukhopadhyay S
    J Pharmacol Exp Ther; 2007 Jun; 321(3):930-7. PubMed ID: 17379772
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distribution of P2X1, P2X2, and P2X3 receptor subunits in rat primary afferents: relation to population markers and specific cell types.
    Petruska JC; Cooper BY; Gu JG; Rau KK; Johnson RD
    J Chem Neuroanat; 2000 Nov; 20(2):141-62. PubMed ID: 11118807
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Subtype-specific regulation of P2X3 and P2X2/3 receptors by phosphoinositides in peripheral nociceptors.
    Mo G; Bernier LP; Zhao Q; Chabot-Doré AJ; Ase AR; Logothetis D; Cao CQ; Séguéla P
    Mol Pain; 2009 Aug; 5():47. PubMed ID: 19671169
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of the endogeneous cannabinoid, anandamide, on neuronal activity in rat hippocampal slices.
    Ameri A; Wilhelm A; Simmet T
    Br J Pharmacol; 1999 Apr; 126(8):1831-9. PubMed ID: 10372827
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The cannabinoid receptor agonists, anandamide and WIN 55,212-2, do not directly affect mu opioid receptors expressed in Xenopus oocytes.
    Kracke GR; Stoneking SP; Ball JM; Tilghman BM; Washington CC; Hotaling KA; Johnson JO; Tobias JD
    Naunyn Schmiedebergs Arch Pharmacol; 2007 Dec; 376(4):285-93. PubMed ID: 17960365
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sodium channel inhibition by anandamide and synthetic cannabimimetics in brain.
    Nicholson RA; Liao C; Zheng J; David LS; Coyne L; Errington AC; Singh G; Lees G
    Brain Res; 2003 Jul; 978(1-2):194-204. PubMed ID: 12834914
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A role for N-arachidonylethanolamine (anandamide) as the mediator of sensory nerve-dependent Ca2+-induced relaxation.
    Ishioka N; Bukoski RD
    J Pharmacol Exp Ther; 1999 Apr; 289(1):245-50. PubMed ID: 10087011
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation of brain-type cannabinoid receptors interferes with preimplantation mouse embryo development.
    Yang ZM; Paria BC; Dey SK
    Biol Reprod; 1996 Oct; 55(4):756-61. PubMed ID: 8879486
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cannabinoids inhibit N- and P/Q-type calcium channels in cultured rat hippocampal neurons.
    Twitchell W; Brown S; Mackie K
    J Neurophysiol; 1997 Jul; 78(1):43-50. PubMed ID: 9242259
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Actions of cannabinoid receptor ligands on rat cultured sensory neurones: implications for antinociception.
    Ross RA; Coutts AA; McFarlane SM; Anavi-Goffer S; Irving AJ; Pertwee RG; MacEwan DJ; Scott RH
    Neuropharmacology; 2001; 40(2):221-32. PubMed ID: 11114401
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A peripheral mechanism for CB1 cannabinoid receptor-dependent modulation of feeding.
    Gómez R; Navarro M; Ferrer B; Trigo JM; Bilbao A; Del Arco I; Cippitelli A; Nava F; Piomelli D; Rodríguez de Fonseca F
    J Neurosci; 2002 Nov; 22(21):9612-7. PubMed ID: 12417686
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.